Affinity Asset Advisors’s Ventyx Biosciences VTYX Stock Holding History

Affinity Asset Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,484,558	Closed	-$58.6M	–	119
2025 Q4	$58.6M	Buy	6,484,558 +2,560,143	+65%	+$19.1M	3.34%	6
2025 Q3	$12.2M	Sell	3,924,415 -611,767	-13%	-$1.62M	1.06%	30
2025 Q2	$9.71M	Buy	+4,536,182	New	+$7.33M	1.33%	26
2023 Q3	–	Sell	-100,696	Closed	-$3.3M	–	94
2023 Q2	$3.3M	Sell	100,696 -159,312	-61%	-$5.49M	1.15%	29
2023 Q1	$8.71M	Buy	260,008 +19,385	+8%	+$754K	2.87%	10
2022 Q4	$7.89M	Buy	240,623 +70,623	+42%	+$2.09M	3.09%	9
2022 Q3	$5.93M	Buy	+170,000	New	+$3.76M	1.66%	16

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Affinity Asset Advisors's VTYX Position: Q1 2026 in Review

Affinity Asset Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 6,484,558 shares — an estimated $58.6M sold.

Affinity Asset Advisors first reported a position in VTYX in Q3 2022 and held it in 7 quarters. The position peaked at $58.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Affinity Asset Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Affinity Asset Advisors sold 6,484,558 Ventyx Biosciences shares in Q1 2026, an estimated $58.6M.
Affinity Asset Advisors first reported a position in Ventyx Biosciences in Q3 2022 and held it in 7 quarters.
Affinity Asset Advisors's Ventyx Biosciences position peaked at $58.6M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.